Ignelzi Troy A.
- SEC CIK
- 0001579829
No open-market purchases or sales filed in the past year.
Current role at each company
- CTNM Contineum Therapeutics, Inc.Directoras of Jun 26, 2026
- HRMY Harmony Biosciences Holdings, Inc.Directoras of Apr 6, 2026
- RAPP Rapport Therapeutics, Inc.Chief Financial Officeras of Feb 4, 2026
- KRTX Karuna Therapeutics, Inc.Chief Financial Officeras of Aug 24, 2023
- CINC CinCor Pharma, Inc.Directoras of Feb 24, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ignelzi Troy A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RAPP Rapport Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 (view filing) | Mar 12-13 | 1 day | Ignelzi Troy A.Chief Financial Officer | PPurchase | +10.0K | $10.10 | +$101.0K | New position10.0K after | 2 lots |
KRTX Karuna Therapeutics, Inc.
Chief Financial Officer11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 (view filing) | Aug 22 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −1.50K | $175.12 | −$262.7K | −4.7%30.5K after | 4 lots10b5-1 |
| May 25, 2023 (view filing) | May 23 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −9.00K | $223.41 | −$2.01M | −22.8%30.5K after | 6 lots10b5-1 |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −6.00K | $190.01 | −$1.14M | −16.4%30.5K after | |
| Jan 19, 2023 (view filing) | Jan 17-18 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −1.02K | $201.16 | −$204.6K | −4.4%21.8K after | 2 lots |
| Nov 17, 2022 (view filing) | Nov 15 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −16.5K | $225.85 | −$3.73M | −62.3%9.97K after | |
| Oct 4, 2022 (view filing) | Sep 30-Oct 4 | 4 days | Ignelzi Troy A.Chief Financial Officer | SSale | −15.0K | $229.61 | −$3.44M | −60.1%9.97K after | 8 lots |
| Aug 11, 2022 (view filing) | Aug 9 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −16.5K | $227.83 | −$3.76M | −39.8%25.0K after | |
| Apr 21, 2022 (view filing) | Apr 19-21 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −4.24K | $131.24 | −$557.0K | −14.5%25.0K after | 3 lots |
| Feb 17, 2022 (view filing) | Feb 15 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −1.50K | $111.14 | −$166.7K | −5.7%25.0K after | |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Ignelzi Troy A.Chief Financial Officer | SSale | −13.5K | $152.32 | −$2.06M | −42.9%18.0K after |